3-YEAR UPDATE OF THE PHASE 2A AND LONG-TERM SAFETY STUDIES (VERTICAL AND VISTA) OF SOMAVARATAN (VRS317), A LONG-ACTING RHGH FOR THE TREATMENT OF PEDIATRIC GROWTH HORMONE DEFICIENCY
HORMONE RESEARCH IN PAEDIATRICS（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要